Expiration date: 01/2025

Ajisept® lemon-flavored

Ajisept® with pineapple flavor

Ajisept® taste of honey

Ajisept® with raspberry flavor

Ajisept® with banana taste

Dosage form

Pastilles for resorption antiseptic 


One pastille for resorption contains:

active ingredients: amylmetacresol........................0, 60 mg., 

alcohol 2, 4-dichlorobenzyl .......1, 20 mg

excipients: sugar 1560, 0 mg, liquid glucose 1010, 0 mg, citric acid anhydrous 24, 0 mg, menthol 5, 22 mg, purified water-sufficient

pineapple flavor-pineapple flavor 0, 0132 ml, quinoline dye yellow WS 0, 181 mg

orange flavor-orange flavor 0, 0108 ml, yellow sunset dye 0, 24 mg

banana flavor - banana flavor 12, 0 mg, quinoline dye yellow WS 0, 1944 mg

lemon flavor-lemon flavor 0, 0108 ml, yellow sunset dye 0, 012 mg, quinoline yellow dye WS 0, 24 mg

raspberry flavored-raspberry flavor 13, 2 mg, carmoisin 19, 44 mg

honey flavor-honey flavor 0, 0096 g, quinoline yellow dye WS 0, 168 mg, caramel color 0, 72 mg.


Pineapple flavored

Yellow round biconvex lozenge with the taste of pineapple and sour taste.

Orange flavored

Orange round biconvex lozenges with orange flavor and sour taste.

Banana flavored 

Yellow round biconvex lozenge with the taste of banana and sour taste.

Lemon flavored

Yellow round biconvex lozenges with lemon flavor and sour taste.

Raspberry flavored

Red round biconvex lozenges with raspberry flavor and sour taste.

Taste of honey

Brownish-yellow, round biconvex lozenge with the taste of honey and a sour taste.

Pharmacotherapeutic group

Drugs for the treatment of throat diseases. Antiseptics. Other drugs.

Code ATSR02AA20


Combined antiseptic preparation with anti-inflammatory effect for topical use in the mouth and pharynx. It has antimicrobial effect. Active against a wide range of gram-positive and gram-negative microorganisms.

Indications for use

  • infectious and inflammatory diseases of the oral cavity and pharynx

Dosage and administration

Adults: 1 lozenge every 2 hours. The maximum daily dose of 8 lozenges.

Pastilles resolves to dissolve.

Side effect


  • allergic reaction


  • hypersensitivity to the drug components
  • children under 18 years

Drug interaction

Clinically significant drug interactions Er® with drugs of other groups.

Special instruction:

When taking the drug to patients with diabetes, it should be borne in mind that each pastille contains 1.56 mg of sugar.

Pregnancy and lactation:

The use of Agisept® during pregnancy and lactation is possible after assessing the benefit/risk ratio for both the mother and the fetus or child.

Features of the effect of the drug on the ability to drive a vehicle or potentially dangerous mechanisms

Agisept® does not affect the ability to drive vehicles and other mechanisms. 


Due to low systemic absorption, overdose is unlikely.

Symptoms: discomfort from the gastrointestinal tract.

Treatment: symptomatic therapy.

Shape of release and packing

6 lozenges in a contour-free packaging made of aluminum foil.

4 contour packaging with the instruction on medical application in the cardboard pack. 

Storage conditions

Store in a dry, dark place at a temperature not exceeding 30°C. 

Keep out of reach of children!

Shelf life

3 years

Do not use after the expiry date indicated on the package.